ALLIANCE PHARMACEUTICAL CORP. WARRANT TO PURCHASE [ ] SHARES OF COMMON STOCK, $.01 PAR VALUE PER SHAREWarrant Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 30th, 2002 Company Industry Jurisdiction
FORM OF SECURITY AGREEMENTSecurity Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 30th, 2002 Company Industry JurisdictionThis SECURITY AGREEMENT, dated as of the 23rd day of July, 2002, made by Alliance Pharmaceutical Corp., a New York corporation (the "Grantor"), in favor of [ ], a [ ] and [ ], a [ ] (the "Secured Parties").
FORM OF PATENT AND TRADEMARK SECURITY AGREEMENTPatent and Trademark Security Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 30th, 2002 Company Industry JurisdictionThis PATENT AND TRADEMARK SECURITY AGREEMENT dated as of the 23rd day of July 2002, made by Alliance Pharmaceutical Corp., a New York corporation, (the "Grantor") in favor of [ ], a [ ] and [ ], a [ ] (collectively, the "Secured Parties").
EQUIPMENT LEASEEquipment Lease • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • California
Contract Type FiledSeptember 30th, 2002 Company Industry JurisdictionLEASE AGREEMENT ("Lease"), dated as of May 29, 2001, between BAXTER HEALTHCARE CORP., a Delaware corporation, having a place of business at One Baxter Parkway, Deerfield, Illinois ("Lessor"), and ALLIANCE PHARMACEUTICAL CORP., a New York corporation, having a place of business at 3040 Science Park Road, San Diego, California ("Lessee").
FORM OF SECURED NOTE PURCHASE AGREEMENTSecured Note Purchase Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances • New York
Contract Type FiledSeptember 30th, 2002 Company Industry JurisdictionTHIS AGREEMENT (this "Agreement") is made as of July 23, 2002, by and among ALLIANCE PHARMACEUTICAL CORP., a New York corporation (the "Company"), [ ], a [ ] and [ ], a [ ] (together, the "Purchasers").
FORM OF PATENT SECURITY AGREEMENTPatent Security Agreement • September 30th, 2002 • Alliance Pharmaceutical Corp • In vitro & in vivo diagnostic substances
Contract Type FiledSeptember 30th, 2002 Company IndustryThis PATENT SECURITY AGREEMENT dated this 23rd day of July 2002, made by Alliance Pharmaceutical Corp., a New York corporation, (the "Grantor") in favor of [ ], a [ ] and [ ], a [ ] (collectively, the "Secured Parties").